Odimmegwa Johnpeter/Abuja
The World Health Organization (WHO) has warned that antimicrobial resistance (AMR) remains one of the most pressing global health threats, calling for urgent, coordinated action across human, animal, agricultural and environmental sectors to prevent millions of additional deaths.
The organisation disclosed that bacterial antimicrobial resistance was associated with more than 4.7 million deaths in 2021, warning that the misuse and overuse of medicines, inadequate infection prevention and poor sanitation continue to fuel the growing threat.
The warning was issued at the 6th Annual Global2 Media Forum on AMR ahead of the 2026 World Antimicrobial Resistance Awareness Week (WAAW), scheduled for November 18 to 24, with the theme, “One Health, One Action: Prevent AMR Now.”
The Director of WHO’s Department of Antimicrobial Resistance and Director of the Quadripartite Joint Secretariat on AMR, Dr Jean-Pierre Nyemazi, described antimicrobial resistance as an urgent global health and development challenge threatening the ability to treat infections, protect animal and plant health, and ensure safe food production.
He said the consequences extended beyond statistics, affecting patients, families, farmers and entire communities.
Nyemazi identified the misuse and overuse of antimicrobial medicines, inadequate infection prevention, poor water and sanitation systems, and environmental contamination as major drivers of AMR.
He noted that although world leaders adopted a Political Declaration on AMR at the 2024 United Nations General Assembly High-Level Meeting, committing to reduce bacterial AMR-associated deaths by 10 per cent by 2030, implementation remained a major challenge.
The declaration also committed countries to ensuring that at least 60 per cent had funded national AMR action plans by 2030 and called for at least 100 million dollars in catalytic funding.
However, Nyemazi said limited financing, fragmented coordination and weak surveillance continued to widen the gap between global commitments and actual implementation.
He disclosed that an updated Global Action Plan on AMR for 2026 to 2036 had been finalised and was expected to be launched at the Fifth Global High-Level Ministerial Conference on AMR scheduled to hold in Abuja, Nigeria, from December 6 to 8, 2026.
He also revealed that efforts were underway to establish the Independent Panel on Evidence for Action against AMR (IPEA), which is also expected to be launched during the Abuja conference.
Nyemazi urged journalists to sustain public awareness and hold governments and other stakeholders accountable through accurate, evidence-based and solution-focused reporting.
” You make visible what is often invisible. Your accurate, evidence-based and solution-focused reporting shapes public understanding, sustains political attention and holds all of us accountable,” he said.
Also speaking, WHO Senior Technical Officer and Lead of Multisectoral Coordination in its AMR Department, Dr Kefas Samson, called on countries to translate global commitments into adequately funded and measurable national interventions.
He identified inadequate financing, weak nationwide surveillance, poor infection prevention in healthcare facilities, limited diagnostic capacity, unequal access to quality-assured antimicrobials and shortages of skilled health workers as major obstacles to progress.
Samson said WHO was supporting governments to assess their needs, cost interventions and strengthen primary healthcare and community-based services to promote infection prevention, early diagnosis and appropriate treatment.
He explained that the updated 2026–2036 Global Action Plan would provide a framework for translating the 2024 UN Political Declaration into measurable country-level action.
Among its targets for 2030 are ensuring that 70 per cent of antibiotics used in human healthcare belong to the WHO Access group and that 80 per cent of countries can test for priority bacterial and fungal pathogens under the Global Antimicrobial Resistance and Use Surveillance System.
The plan also prioritises stronger laboratories, responsible antimicrobial use, equitable access to medicines, resilient supply chains, research, innovation and sustainable financing under the One Health approach.
From the agricultural sector, the Food and Agriculture Organisation of the United Nations (FAO) warned that global antibiotic use in livestock could increase by nearly 30 per cent by 2040 without urgent preventive interventions.
The FAO Deputy Chief Veterinarian and Chief of its One Health and Disease Control Branch, Dr Junxia Song, disclosed that improved animal health and farm management practices could reduce antibiotic use in livestock by as much as 57 per cent.
She stressed that farmers must be placed at the centre of the global response, noting that prevention remained critical to reducing dependence on antibiotics.
Song said the updated Global Action Plan recognised the important role of the agricultural and food production sectors in addressing antimicrobial resistance.
She, however, observed that agricultural priorities remained inadequately integrated and funded in many national AMR action plans, while nearly half of countries had either no or only partial legislation regulating antimicrobial use in animal and plant health.
To address the challenge, she said FAO was implementing a 10-year initiative, Reduce the Need for Antimicrobials on Farms (RENOFARM), built around improved animal health services, better production practices, alternatives and innovation, incentives and partnerships.
She disclosed that more than 400 partners, including over 80 FAO member countries, were already participating in the initiative.
Song also highlighted FAO’s InFARM surveillance system, which has engaged 80 countries in strengthening monitoring of antimicrobial resistance across agri-food systems.
Meanwhile, the United Nations Environment Programme (UNEP) warned that the global response to AMR could be undermined without adequate attention to environmental pollution.
The organisation’s AMR Coordinator in the Chemicals and Health Branch, Aitziber Echeverria, said the environment played a critical role in the emergence, transmission and spread of drug-resistant microorganisms.
She identified pharmaceutical manufacturing, agriculture and food systems, healthcare facilities, and municipal waste and wastewater management as priority areas requiring urgent intervention.
Echeverria called for stronger environmental monitoring, improved wastewater treatment, safe disposal of antimicrobial medicines and increased laboratory capacity.
She also urged governments to integrate environmental authorities into national AMR governance structures, stressing that environmental action was essential to the success of the One Health approach.
According to her, a December 2025 resolution adopted by the United Nations Environment Assembly had strengthened the global mandate for coordinated action on the environmental dimensions of antimicrobial resistance.
Similarly, the World Organisation for Animal Health (WOAH) called for increased investment in animal health systems as a strategy for reducing antimicrobial resistance.
Its Programme Officer, Dr Jane Lwoyero, said every one dollar invested in preventing animal diseases and strengthening animal health systems could generate an estimated 28-dollar return.
She identified vaccination, farm biosecurity, surveillance and veterinary services as essential measures for preventing infections and reducing the need for antimicrobial medicines.
Lwoyero disclosed that animal diseases cause estimated annual global losses of up to 300 billion dollars, while fewer than 20 per cent of WOAH member countries vaccinate animals against notifiable diseases.
She also noted that although global antimicrobial use in animals declined by three per cent between 2019 and 2024, the use of antibiotics for growth promotion remained a concern.
According to her, 74 per cent of countries do not use antimicrobials for growth promotion, while 19 per cent still permit the practice and seven per cent have not reported their position.
She urged countries to end antimicrobial growth promotion, strengthen responsible use of medicines and increase sustainable financing for veterinary services.
In her remarks, Chairperson of the Global AMR Media Alliance (GAMA) and host of the media forum, Shobha Shukla, warned that even minor injuries, including cuts and needle pricks, could expose people to drug-resistant infections that may become difficult or impossible to treat.
She said antimicrobial resistance threatened humans, animals, plants and the environment, stressing the need to preserve antibiotics, antifungals, antivirals and antiparasitic medicines through responsible use.
Shukla said the global challenge had shifted from getting countries to recognise AMR and develop national action plans to ensuring adequate funding, surveillance systems, laboratory capacity and accountability for implementation.
She called for a prevention-first approach that balances reducing unnecessary antimicrobial use with ensuring that people who genuinely need the medicines have access to effective treatment.
The 6th Annual Global Media Forum on AMR brought together representatives of WHO, FAO, UNEP, WOAH and other stakeholders to examine the growing threat and strengthen media engagement ahead of the 2026 World AMR Awareness Week.
END